VCEL Vericel PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: VCEL
- PE Ratio
The current P/E ratio for Vericel stock as of Jun 30, 2025 is 851.0. This is calculated based on the current EPS of $0.05 and the stock price of $42.55 per share. The PE ratio has decreased by 46% from the past four quarters average of 1586.4.
VCEL PE ratio history
The average historical PE ratio of Vericel for the last five years is 1417.56. The current price-to-earnings ratio of 851.0 is 40% less than the historical average. In the past five years, VCEL's PE ratio reached its highest point in the Sep 2021 quarter at 4,880, when the stock price was $48.8 and the EPS was $0.01. The lowest point was recorded in the Dec 2024 quarter, when it reached 261.48 with a price of $54.91 and an EPS of $0.21.
Vericel PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 261.48 | N/A | $54.91 | $0.21 |
| 2023 | N/A | N/A | $35.61 | -$0.07 |
| 2022 | N/A | N/A | $26.34 | -$0.35 |
| 2021 | N/A | N/A | $39.3 | -$0.16 |
| 2020 | 514.67 | N/A | $30.88 | $0.06 |
| 2019 | N/A | N/A | $17.4 | -$0.22 |
| 2018 | N/A | N/A | $17.4 | -$0.2 |
| 2017 | N/A | N/A | $5.45 | -$0.52 |
| 2016 | N/A | N/A | $3 | -$1.18 |
| 2015 | N/A | N/A | $2.58 | -$0.97 |
| 2014 | N/A | N/A | $3.04 | -$2.23 |
| 2013 | N/A | N/A | $3.23 | -$6.95 |
| 2012 | N/A | N/A | $25.2 | -$16.25 |
| 2011 | N/A | N/A | $36.4 | -$10.18 |
| 2010 | N/A | N/A | $29.8 | -$11.8 |
Vericel PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 892.4 | 241.29% | $44.62 | $0.05 |
| Dec 2024 | 261.48 | -56.68% | $54.91 | $0.21 |
| Sep 2024 | 603.57 | -86.84% | $42.25 | $0.07 |
| Jun 2024 | 4,588 | N/A | $45.88 | $0.01 |
| Mar 2024 | N/A | N/A | $52.02 | $0 |
| Dec 2023 | N/A | N/A | $35.61 | -$0.07 |
| Sep 2023 | N/A | N/A | $33.52 | -$0.22 |
| Jun 2023 | N/A | N/A | $37.57 | -$0.28 |
| Mar 2023 | N/A | N/A | $29.32 | -$0.36 |
| Dec 2022 | N/A | N/A | $26.34 | -$0.35 |
| Sep 2022 | N/A | N/A | $23.2 | -$0.38 |
| Jun 2022 | N/A | N/A | $25.18 | -$0.35 |
| Mar 2022 | N/A | N/A | $38.22 | -$0.24 |
| Dec 2021 | N/A | N/A | $39.3 | -$0.16 |
| Sep 2021 | 4,880 | 1,759.05% | $48.8 | $0.01 |
VCEL Price vs fair value
VCEL average PE ratio chart
Currently, VCEL's PE ratio is lower than the 5 and 10-year averages.
VCEL PE vs peers
When compared to its peer stock RPRX, VCEL's PE ratio is higher.
| Stock name | PE ratio | Market cap |
|---|---|---|
| RPRX Royalty Pharma plc | 14.59 | $20.26B |
| VCEL Vericel Corp | 851 | $2.14B |
| NEOG Neogen Corp | N/A | $1.04B |
Frequently asked questions
What is Vericel's PE ratio?
The price to earnings ratio for VCEL stock is 851 as of Jun 30, 2025.
What is the 5-year average PE ratio for Vericel (VCEL)?
The average PE ratio for VCEL stock over the past 5 years is 1498.29.
What is the highest PE ratio for VCEL?
Over the last five years, the quarterly PE ratio reached a historic high of 4,880 in the Sep 2021 quarter.
How does the current PE ratio for VCEL compare to its historical average?
The current price to earnings ratio of VCEL is 40% lower than the 5-year historical average.
Why is Vericel's PE ratio so high?
VCEL's PE ratio of 851 is considered high because the company's stock price is trading at a higher multiple of earnings.
How is VCEL's PE ratio calculated (Vericel PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Jun 30, 2025), Vericel's stock price is $42.55. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.05. Therefore, Vericel's price to earnings ratio for today is 851. PE RATIO(851) = STOCK PRICE($42.55) / TTM EPS($0.05)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.